Pune, India -- (SBWire) -- 08/14/2018 --Market Scenario
Antihistamines are commonly used for the treatment of allergies across the globe. Food and pet allergies are prevalent in various parts of the world. Therefore, the global antihistamine drugs market is expected to grow at a significant rate due to an increase in prevalence of allergic conditions and other diseases, and demand for new drugs for the treatment of these diseases.
The global antihistamine drugs market is expected to grow at a CAGR of 9.8% during the forecast period and is estimated to reach USD 280 million by 2023.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4266
Key Players in the Global Antihistamine drugs Market
Some of the key players in this market are Johnson & Johnson Consumer Inc. (U.S.), Sanofi (France), Bayer AG (Germany), Pfizer (U.S.), CVS pharmacy (U.S.), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (U.S.), and Prestige Brands Holdings, Inc. (U.S.)
Segments
The global antihistamine drugs market is segmented on the basis of types which includes sedating and non-sedating antihistamines. Sedating antihistamines are further sub-segmented into brompheniramine, chlorpheniramine, diphenhydramine, doxylamine, carbinoxamine and others. Non-sedating antihistamines are further sub-segmented into fexofenadine, loratadine, loratadine odt, and others.
On the basis of route of administration, the market is segmented into oral route, parenteral route and rectal route. Parenteral route segmented is further sub-segmented into intramuscular, subcutaneous and intravenous route.
On the basis of indication, the market is segmented into allergy, urticaria, dermatitis, and others. And on the basis of end users, the market is segmented into hospitals, clinics, pharmaceutical companies and others.
Regional Analysis of the Global Antihistamine drugs Market
The American region accounts for the largest share of the global market due to rising prevalence of allergy rhinitis and rising demand for diagnosis and treatment of allergic disease. According to the American College of Allergy Asthma and Immunology, allergic asthma, food allergy, and eczema are the most common types of allergies found in the U.S.
Europe is the second largest market that holds a noticeable share of the global antihistamine drugs market. According to the European Academy of Allergy and Clinical Immunology (EAACI), more than 50% of all Europeans will suffer from allergy in coming years.
In Asia Pacific, increase in the demand for drugs for the treatment of allergies and skin diseases drive the market growth. There has been a rise in the number of dermatology clinics across Asia Pacific from past few years. High rates of allergic rhinitis and increasing awareness regarding treatments available for allergy is poised to drive the growth of this market in Asia Pacific.
The Middle East & Africa, the market shows steady but positive growth due to the rising prevalence of nasal allergies.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4266
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
11 Competitive Landscape
12 Company Profile
13 Conclusion
13.1 Key Findings
13.1.1 From CEO's Viewpoint
13.1.2 Unmet Needs Of The Market
13.2 Key Companies To Watch
13.3 Prediction Of Antihistamine drugs Market
14 Appendix
...Continued
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4266
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Antihistamine Drugs Market to Ascend Pervasively by 2023, Registering 9.8% CAGR; Asserts MRFR